Company intelligence / Profile preview

DEKK-TEC, Inc.

New Orleans, Louisiana, United Statesdekk-tec.com ↗

Ownership: Private
Development stage: Phase 1

Overview

DEKK‑TEC’s lead agent, DM‑CHOC‑PEN, is a proprietary small molecule anti-cancer drug with the unique ability to cross the blood-brain barrier. It is currently in Phase I clinical trials for primary brain cancer and CNS metastases. The compound has shown favorable safety and pharmacokinetic profiles so far. Several other peroxy anticancer agents are at the IND-preparation stage. Two pipeline products have been previously licensed out and advanced to Phase II by partner companies[3].

Therapeutic areas: Women's HealthOncology
Modalities: Small molecules (notably DM-CHOC-PEN and hydroperoxy analogs)
Industry: Biotech

Drug pipeline

3 assets

mipicoledine

2 more assets in the full pipeline.

Request access →

Partnerships

Two pipeline products have been licensed to biotech/pharma partners who advanced them into Phase II clinical development; specific partner names not disclosed publicly as of latest available information[3].

Beyond the preview

Go deeper on DEKK-TEC, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEKK-TEC, Inc..

Explore the full profile